Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
ACS Infectious Diseases|February 1, 2021
Optimization of Benzothiazole and Thiazole Hydrazones as Inhibitors of Schistosome BCL-2William Nguyen, Erinna F Lee, Marco Evangelista, et al.
Bioorganic Chemistry|August 28, 2021
Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activityBrodie L Bailey, William Nguyen, Anna Ngo, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2025
Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasitesEmma Y Mao, William Nguyen, Gouranga P Jana, et al.
PLOS Global Public Health|November 15, 2023
Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trialAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
The American Journal of Tropical Medicine and Hygiene|April 8, 2025
Costs, Coverage, and Acceptability of Azithromycin Mass Administration to Children 1-11 Versus 1-59 Months Old to Reduce Mortality: A Cluster-Randomized Trial in NigerAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
Plos Biology|June 12, 2018
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activationJing Zhao, Lei Zhang, Xiaodong Mu, et al.
ACS Infectious Diseases|December 2, 2025
Deconvolution of the On-Target Activity of Plasmepsin V Peptidomimetics in Plasmodium falciparum ParasitesWenyin Su, William Nguyen, Ghizal Siddiqui, et al.
PLOS Global Public Health|June 26, 2026
Micro-costing for national-scale azithromycin mass drug administration to improve child survival in NigerBrittany Peterson, William Nguyen, Laminou Maliki Haroun, et al.
Journal of Medicinal Chemistry|January 13, 2017
Optimization of 2-Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo ActivityPaul R Gilson, Cyrus Tan, Kate E Jarman, et al.
BMC Public Health|April 30, 2021
Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)Kieran S O'Brien, Ahmed M Arzika, Abdou Amza, et al.
Pageof 9